NT-proBNP for pulmonologists: Not only a rule-out test for systolic heart failure but also a global marker of heart disease

Respiration

Volumn 77, Issue 4, 2009, Pages 370-380

  Wieshammer, Siegfried ^a   Dreyhaupt, Jens ^b   Basler, Beate ^a   Marsovszky, Emil ^a  

^a Klinikum Offenburg   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Dyspnea; Heart disease; Lung disease; Natriuretic peptide; Sensitivity and specificity

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE MARKER; DYSPNEA; FEMALE; HEALTH PRACTITIONER; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PERICARDIAL EFFUSION; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PULMONARY HYPERTENSION; SENSITIVITY AND SPECIFICITY; SYSTOLIC DYSFUNCTION; SYSTOLIC HEART FAILURE; VALVULAR HEART DISEASE;

ADULT; AGED; BIOLOGICAL MARKERS; DYSPNEA; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; PULMONARY MEDICINE;

EID: 67649986922     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000209339     Document Type: Article

References (37)

1. Cowie MR, Struthers AD, Wood DA, Coats AJS, Thompson SG, Poole-Wilson PA, Sutton GC: Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997; 350: 1347-1351.
2. Gustafsson F, Steensgaard-Hansen F, Badskjaer J, Poulsen AH, Corell P, Hildebrandt P: Diagnostic and prognostic performance of N-terminal proBNP in primary care patients with suspected heart failure. J Card Fail 2005; 11(suppl 5):S15-S20.
3. Zaphiriou A, Robb S, Murray-Thomas T, Mendez G, Fox, K, McDonagh T, Hardman SMC, Dargie HJ, Cowie MR: The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study. Eur J Heart Fail 2005; 7:537-541.
4. Wright SP, Doughty RN, Pearl A, Gamble GD, Whalley GA, Walsh HJ, Gordon G, Bagg W, Oxenham H, Yandle T, Richards M, Sharpe N: Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care. A randomized, controlled trial. J Am Coll Cardiol 2003; 42:1793-1800.
5. Moons KGM, Harrell FE: Sensitivity and specificity should be de-emphasized in diagnostic accuracy studies. Acad Radiol 2003; 10 : 670- 672.
6. Rutten FH, Cramer MJM, Grobbee DE, Sachs APE, Kirkels JH, Lammers JWJ, Hoes AW: Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005; 26:1887- 1894.
7. Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E, She D: Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16 : 63-70.
8. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS: Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350:655-663.
9. Sutton TM, Stewart RA, Gerber IL, West TM, Richards AM, Yandle TG, Kerr AJ: Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 2003; 41:2280-2287.
10. Weber M, Hausen M, Arnold R, Moellmann H, Nef H, Elsaesser A, Mitrovic V, Hamm C: Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation. Int J Cardiol 2008; 127: 321-327.
11. Weber M, Arnold R, Rau M, Brandt R, Berkovitsch A, Mitrovic V, Hamm C: Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol 2004; 94:740 -745.
12. Olsen MH, Wachtell K, Tuxen C, Fossum E, Bang LE, Hall C, Ibsen H, Rokkedal J, Devereux RB, Hildebrandt P: N-terminal probrain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study. J Hypertens 2004; 22: 1597-1604.
13. Bando M, Ishii Y, Sugiyama Y, Kitamura S: Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale. Respir Med 1999; 93:507-514.
14. Ishii J, Nomura M, Ito M, Naruse H, Mori Y, Wang J, Ishikawa T, Kurokawa H, Kondo T, Nagamura Y, Ezaki K, Watanabe Y, Hishida H: Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease. Clin Chim Acta 2000; 301:19-30.
15. Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PWF, Sutherland P, Omland T, Vasan RS: Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002; 90: 254-258.
16. Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO, Harris BC, Frohlich ED: Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 2004; 43: 1590 -1595.
17. Nielsen LS, Svanegaard J, Klitgaard NA, Egeblad H: N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea. Eur J Heart Fail 2004; 6: 63-70.
18. Bewick V, Cheek L, Ball J: Statistics review 13: receiver operating characteristic curves. Critical Care 2004; 8: 508-512.
19. Hanley JA, McNeill BJ: A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148 : 839-843.
20. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA; Breathing Not Properly Multinational Study Investigators: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347:161-167.
21. Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, Pinto YM, Richards M: NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients. The International Collaborative of NT-proBNP Study. Eur Heart J 2006; 27:330- 337.
22. Mueller C, Scholer A, Laule-Kilian K, Schindler MB, Buser P, Pfisterer M, Perruchoud AP: Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004; 350: 647- 654.
23. Moe GW, Howlett J, Januzzi JL, Zowall H; for the Canadian multicenter improved management of patients with congestive heart failure (IMPROVE-CHF) study investigators: N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation 2007; 115:3103 -3110.
24. Mogelvang R, Goetze JP, Schnohr P, Lange P, Sogaard P, Rehfeld JF, Jensen JS: Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide. J Am Coll Cardiol 2007; 50:1694- 1701.
25. Davie AP, Francis CM, Love MP, Caruana L, Starkey IR, Shaw TR, Sutherland GR, Mc-Murray JJ: Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ 1996 27;312: 222.
26. Aessopos A, Farmakis D, Taktikou H, Loukopoulos D: Doppler-determined peak systolic tricuspid pressure gradient in persons with normal pulmonary function and tricuspid regurgitation. J Am Soc Echocardiogr 2000; 13:645-649.
27. Chatha K, Alsoud M, Griffiths MJ, Elfatih A, Abozguia K, Horton RC, Dunmore SJ, Gama R: B-type natriuretic peptide in reversible myocardialischaemia. J Clin Pathol 2006; 59: 1216-1217.
28. Cheng TO: Acute dyspnea on exertion is an angina equivalent. Int J Cardiol 2007; 115: 116.
29. Mueller C, Breidthardt T, Laule-Kilian K, Christ M, Perruchoud AP: The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly 2007; 137:4-12.
30. Rutten FH, Cramer MJM, Zuithoff NPA, Lammers JWJ, Verweij W, Grobbee DE, Hoes AW: Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease. Eur J Heart Fail 2007; 9: 651-659.
31. Maisel A, Mueller C, Adams K Jr, Anker SD, Aspromonte N, Cleland JGF, Cohen-Solal A, Dahlstrom U, DeMaria A, Di Somma S, Filippatos GS, Fonarow GC, Jourdain P, Komajda M, Liu PP, McDonagh T, McDonald K, Mebazaa A, Nieminen MS, Peacock WF, Tubaro M, Valle R, Vanderhyden M, Yancy CW, Zannad F, Braunwald E: State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 2008; 10: 824-839.
32. Rutten FH, Hoes AW: B-type natriuretic peptide assays for detecting heart failure in the elderly: same value as those in the younger? Int J Cardiol 2008; 125:161-165.
33. Salpeter SR, Ormiston TM, Salpeter EE: Cardiovascular effects of β-agonists in patients with asthma and COPD: a meta-analysis. Chest 2004; 125:2309-2321.
34. Groenning BA, Raymond I, Hildebrandt PR, Nilsson JC, Baumann M, Pedersen F: Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart 2004; 90: 297-303.
35. Abidov A, Rozanski A, Hachamovitch R, Hayes SW, Aboul-Enein F, Cohen I, Friedman JD, Germano G, Berman DS: Prognostic significance of dyspnea in patients referred for cardiac stress testing. N Engl J Med 2005; 353:1889-1898.
36. Yamaguchi H, Yoshida J, Yamamoto K, Sakata Y, Mano T, Akehi N, Hori M, Lim YJ, Mishima M, Masuyama T: Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol 2004; 43:55-60.
37. Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbély A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL: How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28: 2539-2550.